Product NDC: | 52083-055 |
Proprietary Name: | Supress DX Pediatric Drops |
Non Proprietary Name: | Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride |
Active Ingredient(s): | 5; 50; 2.5 mg/mL; mg/mL; mg/mL & nbsp; Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | SYRUP |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 52083-055 |
Labeler Name: | KRAMER NOVIS |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | part341 |
Marketing Category: | OTC MONOGRAPH FINAL |
Start Marketing Date: | 20110329 |
Package NDC: | 52083-055-01 |
Package Description: | 30 mL in 1 BOTTLE (52083-055-01) |
NDC Code | 52083-055-01 |
Proprietary Name | Supress DX Pediatric Drops |
Package Description | 30 mL in 1 BOTTLE (52083-055-01) |
Product NDC | 52083-055 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride |
Dosage Form Name | SYRUP |
Route Name | ORAL |
Start Marketing Date | 20110329 |
Marketing Category Name | OTC MONOGRAPH FINAL |
Labeler Name | KRAMER NOVIS |
Substance Name | DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE |
Strength Number | 5; 50; 2.5 |
Strength Unit | mg/mL; mg/mL; mg/mL |
Pharmaceutical Classes |